4.5 Article

The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy

Journal

EPILEPSIA
Volume 55, Issue 8, Pages 1229-1234

Publisher

WILEY
DOI: 10.1111/epi.12711

Keywords

Antiepileptic drugs; Pregnancy; Seizures; Lamotrigine; Levetiracetam; Topiramate

Funding

  1. Epilepsy Society of Australia
  2. Royal Melbourne Hospital Neuroscience Foundation
  3. Victorian Epilepsy Foundation
  4. Epilepsy Australia
  5. Sanofi-Aventis
  6. UCB Pharma
  7. Janssen-Cilag
  8. Novartis
  9. Sci-Gen
  10. National Health and Medical Research Council

Ask authors/readers for more resources

Objectives: To assess the effectiveness of the newer antiepileptic drugs (AEDs)-in particular lamotrigine, topiramate, and levetiracetam-in controlling epileptic seizures in pregnant women. Methods: Analysis of data in the Australian Register of Antiepileptic Drugs in Pregnancy concerning seizure control in 1,534 pregnancies in women with AED-treated epilepsies. Results: In AED monotherapy (1,111 pregnancies), use of levetiracetam in pregnancies in the Australian Register was associated with levels of seizure control similar to those that applied for the major older AEDs carbamazepine and valproate, but with levels of seizure control superior to those associated with use of lamotrigine and topiramate. Significance: Levetiracetam shows promise as a satisfactory drug for controlling seizures in pregnancy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available